1-4 of 4
drug safety
Close
Sort by
Journal Articles

A Phase I Study to Investigate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim (Dulastin®) after Single Administration in Pediatric Patients

Kyung Taek Hong, MD, Soyoung Lee, Jaeseong Oh, Jung Yoon Choi, MD, Hee Young Shin, MD PhD, Kyung-Sang Yu, MD PhD, Hyoung Jin Kang, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3594.
https://doi.org/10.1182/blood-2019-125266
Published: 2019
Journal Articles

Real-World Analysis Of Celgene Global Drug Safety (GDS) Database: Early Permanent Discontinuation (D/C) Of Lenalidomide (LEN) In Patients (Pts) With Myelodysplastic Syndromes (MDS) Due To Nonserious (NS) Rash

Lilia Weiss, MD, Dianna Gary, BSN, RN, Arlene S. Swern, PhD, John Freeman, MD, Mary M. Sugrue, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2975.
https://doi.org/10.1182/blood.V122.21.2975.2975
Published: 2013
Journal Articles

The Importance of Press Releases Describing ASH Conference Findings in Translating Research Into Policy: Case Study and Seven-Year Follow-up From a 2004 Oral Presentation

Charles Bennett, MD, PhD, MPP, Adam Kahn, Zaina Parvez Qureshi, PhD, MPH, Sudha Xirasagar, MBBS, PhD, Donald Mattison, M.D., CAPT, USPHS
Journal: Blood
Blood (2011) 118 (21): 4766.
https://doi.org/10.1182/blood.V118.21.4766.4766
Published: 2011
Journal Articles

Rapid Identification of Hematology-Associated Serious Adverse Drug Reactions (sADRS) with Small Datasets: Findings from the Research on Adverse Drug Events and Reports (RADAR) Project.

Nina Undevia, MD MPH, Cara C. Tigue, BA, Dennis P. West, PhD, June M. McKoy, MD MPH JD, Beatrice J. Edwards, MD, David A. Dorr, MD MS, Dennis W. Raisch, RPh PhD, Charles L. Bennett, MD, PhD, MPP
Journal: Blood
Blood (2007) 110 (11): 3339.
https://doi.org/10.1182/blood.V110.11.3339.3339
Published: 2007